Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Malden, MA : WileyBlackwell Pub., 2008-
    • الموضوع:
    • نبذة مختصرة :
      In 2014, we established a pharmacogenetics unit with the intention of facilitating the integration of pharmacogenetic testing into clinical practice. This unit was centered around two main ideas: i) individualization of clinical recommendations, and ii) preemptive genotyping in risk populations. Our unit is based on the design and validation of a single nucleotide polymorphism (SNP) microarray, which has allowed testing of 180 SNPs associated with drug response (PharmArray), and clinical consultation regarding the results. Herein, we report our experience in integrating pharmacogenetic testing into our hospital and we present the results of the 2,539 pharmacogenetic consultation requests received over the past 3 years in our unit. The results demonstrate the feasibility of implementing pharmacogenetic testing in clinical practice within a national health system.
      (© 2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.)
    • References:
      Pharmacogenomics J. 2015 Jun;15(3):201-10. (PMID: 25707393)
      Fed Regist. 1999 Aug 18;64(159):44928-35. (PMID: 12356094)
      PLoS One. 2016 Mar 15;11(3):e0150456. (PMID: 26977927)
      PLoS One. 2012;7(7):e41360. (PMID: 22911785)
      Clin Pharmacol Ther. 2012 Oct;92(4):414-7. (PMID: 22992668)
      Pharmacogenomics. 2016 Jun;17(8):917-24. (PMID: 27248710)
      Pharmacogenomics. 2017 Jul;18(11):1041-1045. (PMID: 28685652)
      Clin Pharmacol Ther. 2017 Sep;102(3):502-510. (PMID: 28090649)
      Pharmacogenomics. 2014 Jun;15(9):1223-34. (PMID: 25141897)
      Mayo Clin Proc. 2014 Jan;89(1):25-33. (PMID: 24388019)
      Clin Pharmacol Ther. 2010 Jan;87(1):74-86. (PMID: 19890254)
      CPT Pharmacometrics Syst Pharmacol. 2017 Mar;6(3):153-155. (PMID: 28109071)
      Public Health Genomics. 2014;17(5-6):287-98. (PMID: 25401385)
      Hum Mutat. 2016 Mar;37(3):315-23. (PMID: 26602992)
      Front Genet. 2012 Nov 26;3:273. (PMID: 23233861)
      Am J Med. 2016 Oct;129(10):1093-1099.e1. (PMID: 27155109)
      Genet Med. 2011 Dec;13(12):987-95. (PMID: 22095251)
      Annu Rev Pharmacol Toxicol. 2015;55:89-106. (PMID: 25292429)
      NPJ Genom Med. 2016 Jan 13;1:15007. (PMID: 29263805)
      Pharmacogenomics J. 2017 Oct;17(5):395-402. (PMID: 28607506)
    • Contributed Indexing:
      Keywords: individualization; pharmacogenetics; precision medicine
    • الموضوع:
      Date Created: 20171202 Date Completed: 20190405 Latest Revision: 20241105
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC5866958
    • الرقم المعرف:
      10.1111/cts.12526
    • الرقم المعرف:
      29193749